Cramer’s lightning round: Hims & Hers Health is not a buy

Business

Loading chart…

Hims & Hers Health Inc: “Hims & Hers lose money … I’m not recommending stocks that are losing a lot of money.”

Loading chart…

Two Harbors Investment Corp: “I’m not going there. We’ve seen a lot of companies like that. … I’m not playing.”

Loading chart…

Shell Midstream Partners LP: “[Enterprise Product Partners], that’s the best one if you want to be in that group now.”

Loading chart…

Healthcare Realty Trust Inc: “I thought [the company’s merger with Healthcare Trust of America] made a lot of sense. … I like it.”

Loading chart…

DraftKings Inc: “[Kynikos Associates founder] Jim Chanos says it’s a great short. I think the time to short the stock was much, much higher.”

Loading chart…

Gilead Sciences Inc: “I know it looks very, very cheap. But you know what, that’s not why we buy drugs stocks. We buy drug stocks because they’ve got growth, and Gilead has none.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? [email protected]

Articles You May Like

Bond yields are climbing. Here’s what that means for mortgages and other consumer borrowing
Refiner stocks are on a nearly unprecedented run. History says it could end soon
How big is the great wealth transfer? It could be over $100 trillion or $36 trillion
Tariff bills across U.S. states mount as affordability and Trump head for midterm elections showdown
Disney CEO Josh D’Amaro tells CNBC parks were ‘big surprise’ in last quarter, company has ‘clarity’ and ‘stability’

Leave a Reply

Your email address will not be published. Required fields are marked *